Based on 8 analysts giving stock ratings to ProMIS Neurosciences Inc in the past month.
In the current month, PMN has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PMN average Analyst price target in the last month is 44.917.
Based on analysts' estimates, PMN EPS is projected to reach -1.112 in FY2026Q4, following reported EPS of -0.893 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.89, while ProMIS Neurosciences IncPMN's earnings per share (EPS) for the previous quarter was USD -1.28. EPS for the next quarter is expected at USD -1.11.